Reciprocal relationship from PFE graph: Reciprocal relationship from CELC graph: The Company entered into a license agreement with Pfizer to research, develop, manufacture and commercialize gedatolisib.
Celcuity Inc. Customers
No clients on recordNo downstream customers found in our database for Celcuity Inc..
Celcuity Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CELC-DEBT-8579
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2025-12-31.
CELC-DEBT-8578
Warrants outstanding: 1827357
90%
xbrl warrant detail from xbrl 2025-12-31.
CELC-DEBT
Debt stack $323.4M
90%
Market cache reports total debt of $323.4M.
Celcuity Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Celcuity Inc..
Celcuity Inc. Ownership
Holder
Name
Confidence
Evidence
CELC-OWNER-BAKER-BROS-ADVISORS-LP
BAKER BROS. ADVISORS LP
90%
13F overlay lists BAKER BROS. ADVISORS LP as top holder; 281 tracked holders.